Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 6.800 SEK | -2.02% |
|
-6.08% | +27.34% |
| 09:04am | Calendar Friday, August 21 | FW |
| 08-13 | Five stocks have so far today hit new 52-week highs on the Stockholm Stock Exchange | FW |
| Market Cap | 3.23B 340M 292M 272M 250M 469M 32.58B 478M 1.26B 16.33B 1.28B 1.25B 54.05B | P/E 2026 * |
66.3x | P/E 2027 * | -17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.68B 282M 242M 225M 207M 389M 27.01B 396M 1.04B 13.54B 1.06B 1.04B 44.81B | EV / Sales 2026 * |
6.15x | EV / Sales 2027 * | 8.77x |
| Free-Float |
40.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Egetis Therapeutics AB
| 1 day | -3.03% | ||
| 1 week | -6.08% | ||
| Current month | +13.33% | ||
| 1 month | +6.75% | ||
| 3 months | +1.49% | ||
| 6 months | +42.56% | ||
| Current year | +27.34% |
| 1 week | 6.73 | 7.28 | |
| 1 month | 5.86 | 7.35 | |
| Current year | 4.23 | 7.35 | |
| 1 year | 3.62 | 7.35 | |
| 3 years | 3.02 | 9.3 | |
| 5 years | 3 | 9.3 | |
| 10 years | 3 | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/13/26 | Sell | Chief Executive Officer | -286,071 | 0.0724% | ||
| 5/11/26 | Fiscal year | Chief Financial Officer | 264,880 | 0.0670% | ||
| 1/16/26 | Buy | Chairman | 150,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.02% | -6.08% | +27.10% | +64.25% | 341M | ||
| +2.38% | +5.57% | +86.02% | +115.89% | 72.21B | ||
| +0.87% | +17.34% | +57.17% | +94.08% | 63.98B | ||
| -3.60% | -0.20% | -2.60% | +473.09% | 28.53B | ||
| +3.63% | +8.62% | +66.69% | +23.95% | 25.07B | ||
| -2.14% | +20.54% | -0.23% | -5.52% | 28.42B | ||
| -0.51% | +5.73% | +38.71% | -14.19% | 20.04B | ||
| -1.79% | -4.51% | +241.26% | +414.48% | 18.19B | ||
| +1.81% | +0.85% | +16.89% | +546.06% | 15.96B | ||
| -0.81% | +6.84% | +42.82% | +153.02% | 13.48B | ||
| Average | -0.33% | +4.66% | +57.38% | +186.51% | 28.62B | |
| Weighted average by Cap. | +0.44% | +7.46% | +61.08% | +162.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 435M 45.9M 39.3M 36.67M 33.65M 63.23M 4.39B 64.47M 170M 2.2B 172M 169M 7.29B | 328M 34.59M 29.61M 27.63M 25.35M 47.64M 3.31B 48.58M 128M 1.66B 130M 127M 5.49B |
| Net income | 342M 36.06M 30.88M 28.81M 26.43M 49.67M 3.45B 50.65M 133M 1.73B 135M 132M 5.73B | -117M -12.34M -10.57M -9.86M -9.05M -17M -1.18B -17.34M -45.6M -592M -46.34M -45.34M -1.96B |
| Net Debt | -552M -58.22M -49.85M -46.51M -42.68M -80.19M -5.57B -81.77M -215M -2.79B -219M -214M -9.24B | -353M -37.25M -31.9M -29.76M -27.31M -51.31M -3.56B -52.32M -138M -1.79B -140M -137M -5.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | SEK 6.800 | -2.02% | 574,661 |
| 26-08-19 | SEK 6.940 | -1.14% | 580,491 |
| 26-08-18 | SEK 7.020 | -0.99% | 512,294 |
| 26-08-17 | SEK 7.090 | -0.98% | 433,837 |
| 26-08-14 | SEK 7.160 | -1.10% | 661,887 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Select your edition
All financial news and data tailored to specific country editions

















